Data as of November 13, 2026

Lamivudine 150 mg Tablet

LAMIVUDINE

Brand: Lamivudine

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$19.49/ fill$0.48 / EA
Cost Plus Drugs (retail)
$10.55/ fill$0.26 / EA
FUL
$21.82/ fill$0.54 / EA
AMP
$12.47/ fill$0.31 / EA
Medicaid FFS
$40.82/ fill
Medicaid MCO
$48.99/ fill

Sources: cms/nadac:price-ladder · costplusdrugs/price-list · cms/ful:generic-ceiling · cms/sdud. Cost Plus prices as of 2026-11-13

What's in the reimbursement

Ingredient cost (40.6 units/fill)$19.49
Dispensing fee & other (state-fixed, not margin)$21.33
Total reimbursed per fill$40.82

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 3 fee-for-service states, 6 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology